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A B S T R A C T
In order to assess the role of continuous intracerebral infusion of GABA over the propagation of
generalized seizures from the amygdala, Wistar rats were subjected to a kindling procedure at the left
basolateral amygdala. Subsequently, they were implanted with miniosmotic pumps ﬁlled with 100 mg/
mL of GABA in saline, connected to catheters whose tips were placed bilaterally at both dorsomedian
nuclei of the thalamus (DMNT). The threshold intensity to provoke local afterdischarges (ADT) and
generalized seizures (GST) were measured before, during and after GABA infusion, as well as seizure
intensity and signs of ataxia and sedation.
While there was no observed variation on ADT, the median GST was signiﬁcantly increased during,
but not after infusion of GABA (P = 0.047, compared to the preinfusion value). Seizure intensity was not
changed. No signs of neurologic side effectswere recorded. These data emphasize the role of DMNT in the
generalization of seizures originated at the amygdala.
 2009 Published by Elsevier Ltd on behalf of British Epilepsy Association.
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Complex partial seizures generalize through well deﬁned
anatomic pathways. The dorsomedian nucleus of the thalamus
(DMNT) is well connected to the amygdala and other limbic
structures and may have an important role in the propagation of
these seizures.1,2
Lesions in DMNT disrupt the propagation of some experimental
seizures in rats.3 In the sameway, drug infusion in the DMNT could
modulate the intensity of limbic seizures. Seizure duration can be
reduced by acute infusion of the GABA agonist muscimol, and can
be prolonged by the acute infusion of the GABA antagonist
bicuculline.4 Likewise, bilateral injection in DMNT of glutamate
antagonists or GABA agonists inhibits seizures provoked by
systemic pilocarpine.5 Also, ipsilateral DMNT injection of similar
drugs inhibits generalization of limbic seizures acutely induced by
infusion of bicuculline at the ‘‘area tempestas’’.2 However, clinicalAbbreviations: GABA, g-aminobutyric acid; DMNT, dorsomedian nucleus of the
thalamus; ADT, afterdischarge threshold; GST, generalized seizure threshold; ST,
seizure threshold; SS, seizure severity.
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provided by chronic administration of the drugs. We have shown
that continuous infusion of GABA via osmotic minipumps at the
amygdala may increase the threshold to provoke local after-
discharges and clinical seizures in amygdala-kindled rats.6 The use
of this chronic model of limbic seizures may be useful to replicate
human partial complex seizures with secondary generalization,7,8
and therefore to explore the role of chronic intracerebral drug
infusion in the clinical setting.
Another advantage of the amygdala-kindlingmodel is that once
animals are fully kindled, further stimulations do not change the
variables that deﬁne the model,8 so it is possible to repeat the
experiments daily for an extended period. This suits to the clinical
practice, since patients use to be treated after having developed
epilepsy, not preventively.
The aim of this study is to test the effect on seizures and
neurologic side effects of bilateral continuous GABA infusion
within the DMNT in amygdala-kindled rats.
2. Materials and methods
We used adult male Wistar rats, bred in the facilities of the
Research Centre of the University General Hospital in Valencia
(Spain). The experimental protocol was approved by the corre-
sponding institutional animal care committee, in compliance withEpilepsy Association.
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ECC) andwith those set by the Valencian Community Government.
Under general anesthesia afforded with an intraperitoneal
injection of a mixture of ketamine (100 mg/kg), diazepam (8 mg/
kg) and atropine sulphate (0.4 mg/kg), animals weighting 270–
310 g were stereotactically implanted with a bipolar electrode at
the left basolateral amygdala. The electrode consisted of a twisted
pair of 0.2 mm diameter Teﬂon-coated stainless steel wires
(Advent Research Materials, Suffolk, England), the tips of which
were exposed by 0.2 mm and separated by 0.5 mm, and then
placed at the following coordinates: 2.2 mmposterior, 4.8 mm left,
and 8.5 mm ventral from the bregma.9 Also, two cannulae made of
stainless steel (0.7 mm outer diameter) were stereotactically
implanted bilaterally at coordinates corresponding to the DMNT:
2.8 mm posterior, 0.7 mm lateral and 5.4 mm ventral), with a
lateral inclination of 158 in order to avoid the superior longitudinal
sinus.
Four symmetrical, chlorinated, silver recording electrodes were
implanted into the epidural space (two frontal and two occipital).
In addition, an indifferent electrode was placed under the skin of
the neck. All electrodes were connected to a 7-pin miniature
connector. The cannula, electrodes and connector were ﬁxed to the
skull vaultwith dental acrylic cement, and the skinwas closedwith
silk suture at both ends of the incision. After surgery, animals were
individually caged.
A standard kindling procedure commenced 10 days after
surgery, which involved daily stimulation with a 1-s train of 50 Hz
square wave pulses (1 ms duration and 500mA amplitude), using a
Grass S88 stimulator, until more than three consecutive stage 5
seizures10 were provoked. At this point, the animal was considered
fully kindled, and the afterdischarge threshold (ADT) and seizure
threshold (ST)were determined. This was done by using a stepwise
ascentmethod,11 consisting of stimulationwith a series of 1-s train
of 50 Hz square wave, in pulses lasting 1 ms, separated by 1 min
intervals. Current intensity began at an amplitude of 7mA and was
increased gradually, by 20% each step, to 500 mA, or until a
behavioral seizure occurred. The amplitude reached when a
seizure was produced was considered to be the ST. Similarly,
the lowest amplitude to elicit an afterdischarge recorded from the
amygdalar electrode of at least 5 s was considered to be the ADT.
This procedure was repeated over the following 2 days, and the
median of the three determinations was considered as the control
threshold value.
After basal seizure readings were taken, animals were assigned
to one of two groups: those receiving bilateral GABA infusion
(n = 7), or bilateral sham infusion of hyperosmotic saline (n = 2).
They were anesthetised once more with the same intraperitoneal
injection mixture as previously described, and two miniosmotic
pumps (Alzet model 2001, with outer dimensions 3.0 cm  0.7 cm,
200 mL reservoir volume and infusion rate of 0.5 mL/h, Alza Corp.,
California) were subcutaneously implanted in the upper dorsal
region. Pumps were ﬁlled either with a 100 mg/mL GABA solution
in saline, or a saline concentrationwith osmotic pressurematching
that of 100 mg/mL GABA, and were connected to a silicone tube
(50 mm long, 0.5 mm inner diameter), which was ﬁlled with the
same solution after the pump had been incubated in a saline bath
for 1 h at 37.5 8C. The tubes were connected to both DMNT
catheters accordingly.
The anticonvulsant efﬁcacy and the neurologic side effects were
determined at the same time each day over two 5 consecutive day
period the next 2 weeks, starting 48 h after pump implantation. As
the pump works for only 7 days, the ﬁrst week was considered as
the infusion period and the second week the postinfusion period.
Measures of these experiments were performed by investigators
who were blinded to the actual treatment of the animal. The
anticonvulsant effect determinationwas performed by stimulationof the left amygdala. The ADT and the ST were measured using the
stepwise ascent method described in the previous section; when a
generalized seizure was produced, the ST was considered as the
generalized seizure threshold (GST). Afterdischarge duration
(ADD), i.e., the time elapsed between the onset of epileptiform
electric activity and its disappearance, and seizure duration (SD),
i.e., the time between the onset of seizure-like behavior and its
disappearance, were also recorded. Also, seizure severity (SS),
measured on the Racine scale,10 was determined. Neurological side
effects were tested immediately prior to stimulation by means of
an observational neurological examination, and then scoring
ataxia and sedation according to the following scales12; ataxia:
0 = absent; 1 = slight ataxia in hindlegs; 2 = more pronounced
ataxia with dragging of hindlegs; 3 = further increase of ataxia and
more pronounced dragging of hindlegs; 4 = marked ataxia and loss
of balance during forward locomotion; 5 = considerably marked
ataxia with frequent loss of balance; 6 = permanent loss of righting
reﬂex; sedation: 0 = absent; 1 = slightly reduced forward locomo-
tion; 2 = reduced locomotion with rest periods between periods of
locomotion; 3 = reduced locomotion with more frequent rest
periods; 4 = no forward locomotion and the animal sits still with
closed eyes.
Once the experiments were completed, animals were sacriﬁced
with an intraperitoneal injection of pentobarbital, and the pumps
explanted and inspected to conﬁrm adequate voiding. Gross
inspection showed a proper position of the electrode tip and
catheters, although this was not histochemically conﬁrmed.
Wilcoxon’s signed rank test for paired replicates13 was used to
calculate the signiﬁcance of individual differences between seizure
parameters during and after GABA infusion against controls of the
same animals before GABA infusion. Statistical signiﬁcance was
considered when P < 0.05.
3. Results
Results are summarized in Table 1. In the GABA infusion group,
no signiﬁcant changes were observed in ADT, which was stable
through the whole experiment (Fig. 1). On the other hand, SS
showed a wide variability in the GABA infusion group. Therefore
some animals infused with GABA showed a complete suppression
of seizures, but some others had no changes. As amatter of fact this
result was not statistically signiﬁcant.
Results on GST also marked a great variability among different
animals and among different days of the week. A signiﬁcant
elevation (P = 0.047) of the median GST, was shown during the
week of infusion (but not in a day by day basis) in the GABA
infusion group as compared to the preinfusion value (Fig. 1). In the
postinfusion period, the GST showed a trend towards basal values,
showing no signiﬁcant difference with preinfusion values.
On the contrary, no signiﬁcative change was observed in any of
the kindling parameters in the animals receiving bilateral infusion
of control solution.
No neurologic side effect was observed in any of the groups.
4. Discussion
Focal treatment for epileptic patients in the place where
seizures originate is not always possible, since sometimes the
location of this place cannot be established, or it can be extensive
or multiple, or its inhibition can lead to adverse effects worse than
the epileptic condition. In such cases, instead of the epileptogenic
area, it may be better to inhibit the pathways which propagate
epileptic activity to the rest of the brain.
Some approaches involving the increase activity of inhibitory
centers have been considered, such as stimulation of the
cerebellum,14 the striatum15 or the subthalamic nucleus.16 Also,
Table 1
Effect on the seizure parameters recorded before (preinfusion), during (days 3–7) and after (days 10–14) continuous bilateral infusion of GABA in the dorsomedian nucleus of
the thalamus. Each parameter is expressed as median (minimum, maximum). ADT, afterdischarge threshold (mA); ADD, afterdischarge duration (s); GST, generalized seizure
threshold (mA); GSD, generalized seizure duration (s); SS, seizure severity (Racine’s score).
Previous to infusion Infusion period
Day 3 Day 4 Day 5 Day 6 Day 7
Control
ADT 155 (155–155) 142 (129–155) 155 (155–155) 155 (155–155) 155 (155–155)) 155 (155–155)
ADD 60.5 (6–115) 69.5 (4–135) 41 (7–75) 112.5 (110–115) 92.5 (10–175) 65 (40–90)
GST 270.5 (155–386) >384 (268–>500) 188.5 (155–222) 211.5 (155–268) 211.5 (155–268) 327 (268–386)
GSD 130 (115–145) 300 (300–300) 90 (75–105) 77.5 (40–115) 102.5 (30–175) 70 (10–130)
SS 5 (5–5) 2. 5 (1–4) 5 (5–5) 4.5 (4–5) 4.5 (4–5) 4.5 (4–5)
GABA 100
ADT 155 (90–155) 155 (90–500) 129 (90–155) 155 (90–322) 187.5 (75–268) 155 (108–322)
ADD 25 (6–120) 10 (5–110) 15 (6–80) 10 (4–128) 15.5 (5–70) 5 (4–50)
GST 155 (108–322) 186 (155–>500) 186 (108–>500) 222 (129–>500)) 304.5 (129–>500) 322 (155–>500)
GSD 110 (60–150) 100 (90–120) 77.5 (70–80) 95 (80–100) 70 (11–110) 100 (20–110)
SS 5 (5–5) 5 (1–5) 5 (1–5)) 5 (1–5) 5 (1–5) 5 (1–5)
Postinfusion period
Day 10 Day 11 Day 12 Day 13 Day 14
Control
ADT 108 (108–108) 142 (129–155) 155 (155–155) 170.5 (155–186) 203 (186–220)
ADD 150 (150–150) 89.5 (39–140) 15 (10–20) 15.5 (8–23) 7.5 (6–9)
GST 268 (268–268) 354 (322–386) 245 (222–268) 244 (220–268) 295 (268–322)
GSD 120 (120–120) 147.5 (100–195) 118 (116–120) 120 (105–135) 134.5 (106–163)
SS 5 (5–5) 5 (5–5) 5 (5–5) 5 (5–5) 5 (5–5)
GABA 100
ADT 155 (155–186) 155 (155–222) 155 (62–220) 170.5 (52–268) 155 (52–388)
ADD 75 (17–125) 40 (10–95) 100 (26–120) 27.5 (4–120) 12 (4–30)
GST 186 (155–386) 211.5 (155–322) 155 (62–>500) 322 (52–>500) >500 (90–>500)
GSD 75 (20–125) 80 (30–100) 100 (40–120) 100 (100–120) 70 (5–120)
SS 5 (4–5) 5 (2–5) 5 (5–5) 5 (0–5) 5 (1–5)
Fig. 1.Median values for ADT and GST during the preinfusion, infusion and postinfusion periods. Preinfusion values are the median of the 3 days previous to implantation of
pums. Infusion values are the median of the 3–7 days postimplantation and postinfusion values are the median of the 10–14 days postimplantation median GST was
signiﬁcatively increased in the infusion period (P = 0.047) as compared to the basal value. The open symbols and asterisk in the ADT panel mean atypical and extreme values,
respectively.
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propagation. For example, centromedian thalamic inhibitory
electric currents may control absence seizures in patients.17 Also,
stimulation of the anterior nucleus of the thalamus may inﬂuence
the generalization of seizures.18 Similar effects may be obtained by
injection of GABA agonists in other thalamic nuclei.19Focal seizures of limbic origin propagate through anatomically
well deﬁned pathways.1 The main thalamic projection of the
amygdala is to the DMNT, especially its medial part. This projects
to the orbitofrontal cortex and is more important in man than in
other mammals. It makes the DMNT a suitable target to block
propagation of seizures originating from the amygdala. Lesion or
J.M. Gallego et al. / Seizure 18 (2009) 537–540540acute injection of glutamate antagonists or GABA agonists at the
DMNT inhibits generalization of experimental seizures.2–5 Our
data show that GABA infusion in the DMNT gets a mild but
signiﬁcant inhibition of the generalization of epileptic seizures
during the infusion period. There is no effect on the focal seizure
activity, which suggests that GABA does not reach the amygdala,
where seizures originate, in a sufﬁcient amount. We showed in an
earlier experiment that local infusion of GABA in the amygdala
elevates the ADT.6
In order to transfer these results to the clinic, it is necessary to
maintain the inhibitory effect in a chronic basis. Continuous local
infusion of GABA may inhibit local brain function, as Will et al.20
showed by locally infusing GABA into the nucleus basalis of the rat.
The basis for intracerebral GABA infusion as a treatment for
epilepsy is the restoration of the imbalance between glutamatergic
and GABAergic synaptic transmission.21 This approach has been
used to block the behavioral manisfestations of seizures in amodel
of limbic seizures by cortically infusing GABA.22 This was followed
by spontaneous afterdischarge generation when GABA infusion
was stopped.
In our experiment, the anticonvulsant effect is not maintained
during the postinfusion week, which supports the causative effect
of GABA during the infusion and the reversibility of the effect.
On the other hand, this effect of the GABA infusion consists of
higher GST, but there are not signiﬁcant changes in seizure severity
scored according to Racine.10 This means that, once propagated,
seizures develop fully in spite of the thalamic block. This could be
explained by increased connectivity between amygdala and frontal
cortex as a result of kindling.23
Surgical alternatives to antiepileptic drugs are consideredwhen
drug resistant seizures develop. Although the strategy considered
here does not rely in augmenting the bioavailability of the drug at
the epileptic area, but rather in blocking the spread of the seizures,
it would be interesting to study the differential effect of this
treatment on drug resistant rats. The kindling model of epilepsy
permits the selection of animals resistant to speciﬁc drugs (e.g.,
phenytoin),7 as thus it would be possible to determine if GABA
infusion within the NDMT is valid in phenytoin resistant animals.
Technically, focal delivery of GABA bymeans of external pumps
may jeopardize its clinical use, since issues of recharging the
contents of the pumpmay be raised. Amore stablemeans to locally
deliver GABA could be the implantation of genetically modiﬁed
GABA producing cells, as other authors have used at the pyriform
cortex24 or the dentate gyrus.25 Also, NDMT could be an alternative
target for deep brain stimulation in drug resistant temporolimbic
epilepsy.18
In conclusion, this study shows that continuous bilateral
infusion of GABA in the dorsomedian nucleus of the thalamus
elevates the generalized seizure threshold in amygdala-kindled
rats, without affecting afterdischarge threshold. This shows the
possibility to inhibit the generalization of seizures without acting
on the epileptogenic area. New techniques should be developed to
deliver GABA in the pathways of propagation of seizures as a
treatment of epilepsy.References
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